Nyxoah SA
NYXHHealthcareNASDAQMedical Devices · Last scanned Oct 24, 2026
Scan Results
Daily timeframePart of the healthcare sector, Nyxoah SA (NYXH) is listed under Medical Devices. With a market capitalization of $85.0M, it sits in micro-cap territory. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Market Cap
$85.0M
Beta
1.00
P/E (TTM)
—
P/E (Fwd)
-1.01
EPS (TTM)
$-2.56
EPS (Fwd)
$-0.82
ROE
-122.7%
ROA
-36.9%
Cash
$97.8M
Total Debt
$60.0M
Free CF
-$46.1M
52W Change
-85.1%
Annual Financials
Cash vs Debt
Where NYXH stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, NYXH finished 54.33% below its 150-day moving average ($2.08) and 64.55% below its 200-day moving average ($2.68). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NYXH overbought or oversold?
At the October 20, 2026 close, NYXH's RSI(14) was 18.3, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Nyxoah SA holds $97.8M in cash against $60.0M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$46.1M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -122.7%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $852K (2021) to $10.0M (2025), reflecting a 1076% increase over the period.
The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Nyxoah SA's trajectory.